Dusseldorf - Delayed Quote EUR
Terns Pharmaceuticals Inc (430.DU)
2.5000
-0.0800
(-3.10%)
As of 4:00:10 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-70,016
-70,016
-67,390
-49,109
-41,827
Investing Cash Flow
-12,410
-12,410
-37,987
-22,272
-119,696
Financing Cash Flow
163,995
163,995
41,951
167,095
134,393
End Cash Position
161,439
161,439
79,926
143,235
47,699
Income Tax Paid Supplemental Data
60
60
28
3
238
Capital Expenditure
-42
-42
-52
-275
-340
Issuance of Capital Stock
162,312
162,312
41,611
167,253
136,362
Repayment of Debt
--
--
--
--
-12,880
Free Cash Flow
-70,058
-70,058
-67,442
-49,384
-42,167
12/31/2021 - 4/1/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade